21 results
IDSA 2017 CDiff Guidelines - Table 1. Recommendations for the Treatment of Clostridium difficile Infection in Adults

#Management
IDSA 2017 CDiff ... Guidelines - Table ...  1. ... Infection in Adults ... #Management #
IDSA 2017 CDiff Guidelines - Table 7. Potential Treatment Agents for Treatment of the Primary Clostridium difficile
IDSA 2017 CDiff ... Guidelines - Table ... infection Episode ... #Pharmacology #Management ... #CDifficile #IDSA2017
IDSA 2017 CDiff Guidelines - Table 2. Recommendations for the Treatment of Clostridium difficile Infection in Children

#Management
IDSA 2017 CDiff ... Guidelines - Table ... Infection in Children ... #Management # ... #Clostridium #CDifficile
IDSA Recommendations for Preventing and Treating Bacterial Enteric Infections in HIV-AIDS
Preventing Bacterial Enteric Illness:
 • Antimicrobial
IDSA Recommendations ... Treating Clostridium difficile ... Enteric #Bacterial #IDSA ... #Prevention #Treatment ... #management #opportunistic
C.diff - Clostridioides Difficile Infection (CDI) - Diagnosis and Management - GrepMed Handbook

Clinical Presentation + Progression:
Difficile Infection ... Diagnosis and Management ... Epidemiology: • #1 ... 10 mg/kg IV x 1 ... ciab549 #CDI #Cdiff
IDSA Recommendations for Preventing Human Papillomavirus Infections and Cervical Cancer Screening for Women with in HIV-AIDS
Recommendations
IDSA Recommendations ... screen within 1 ... 0.5mL IM at 0, 1– ... #Prevention #Treatment ... #management #opportunistic
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS
Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days)
Preferred
IDSA Recommendations ... chew, or crush tablet ... 4–6 mL QID or 1– ... #management #opportunistic ... #infections #HIVAIDS
Potential Treatment Agents for Treatment of the Primary Clostridium difficile infection Episode
Proven efficacy:
 • Vancomycin -
Primary Clostridium difficile ... infection Episode ... × 10 days #CDiff ... #management #pharmacology ... #idsa #table
IDSA Recommendations for Treating Herpes Simplex Virus (HSV) Infections in HIV-AIDS
Treating Orolabial Lesions (Duration: 5–10 days)
IDSA Recommendations ... • Valacyclovir 1 ... • Valacyclovir 1 ... • Continue treatment ... #management #opportunistic
IDSA Recommendations for Preventing and Treating Toxoplasma gondii Encephalitis in HIV-AIDS
Indications for Initiating Primary Prophylaxis:
 •
IDSA Recommendations ... #Prevention #Treatment ... #opportunistic ... #infections #HIVAIDS ... #management #pharmacology